ENDOTOXIN-FREE GROWTH FACTORS INCREASE REPRODUCIBILITY OF STEM CELL RESEARCH
Endotoxins (lipopolysaccharides; LPS) are produced and released by bacteria such as E. coli, which is the most common bacteria used to produce commercial growth factors.
Studies have now revealed that endotoxin contamination accepted in E. coli produced growth factors (1 EU/µg or 0,1 ng/µg), can affect cell cultures. This reduces reproducibility of cultivations, since small fluctuations in these endotoxin contaminants between lots of even the same growth factor, will have varying, unpredictable effect on the cell culture. Therefore, applying endotoxin-free growth factors increases precision and reproducibility of cultures.
- Increased reproducibility leads to more consistency in stem cell experiments
- Increased reproducibility saves time and resources
- Increased reproducibility leads to smoother transfer of an already established stem cell culture protocol from pre-clinical research to clinical trials.
Extensive accumulated data clearly suggests that the endotoxin limits generally allowed in E. coli produced growth factors pose a threat to stem cell research.
Please follow the links below one by one to view data supporting that low endotoxin concentrations
are unsafe for stem cell cultures.
Inhibition of directed differentiation of hESC to mesoderm
Direct effect on myeloid progenitor cells alters hematopoietic precursor cells
Altered physical behaviour of endothelial cells
ISOkine™ Endotoxin-free Growth Factors & Cytokines
- Lower list prices than market leaders
- Standard bioactivity on par with market leaders
ORF Genetics has developed a new innovative and unique approach in
the manufacturing of growth factors and hard-to-produce recombinant
proteins, bypassing the use of bacterial or animal cell systems. By
using barley as a production host, ORF Genetics is able to offer
high-grade, animal-free and endotoxin-free growth factors.
ISOkine growth factors typically contain more than 200 times
lower levels of endotoxins than are allowed in most other commercially
available growth factors.
Kristinn D. Gretarsson appointed CEO of ORF Genetics and Sif Cosmetics
ORF Genetics announced today that Mr. Kristinn D. Gretarsson has been
appointed CEO of the company and its subsidiary, Sif Cosmetics.
Endotoxin-free growth factors for stem cell research in Trends in Biotechnology
The advantages of endotoxin-free production of growth factors and other
recombinant proteins in barley is the subject of a review article by Dr.
Audur Magnusdottir and colleges at ORF Genetics, published in Trends in
ORF Genetics‘ ISOkine growth factors– The Best European Biotechnology Product in 2013
At the European Biotechnology Congress in Bratislava last week, the
ISOkine growth factors produced by ORF Genetics were chosen this year’s
Best Biotechnology Product in the category of innovative products that
solve or tackle important problems in human health. The awards are given
in recognition of distinguished contribution to the European
Biotechnology Industry, by a small or medium sized European company.